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Previewsoccurs on a variety of cell types and is
connected to multiple signaling networks.
Restoring community diversity with obli-
gate anaerobes, such as Barnsiella, Bac-
teroides, or Ruminococcus, could also
be worthwhile. The findings of Pham and
colleagues, however, suggest a direct
and simpler approach: administration of
fucosylated oligosaccharides, such as
20-fucosyllactose, which may do much to
restore community complexity and pro-
mote homeostasis.
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In this issue of Cell Host & Microbe, Hammer et al. (2014) show that distinct, slow-growing bacteria have bet-
ter in vitro and in vivo growth and virulence when cocultured than in isolation. They provide evidence that the
observed inter- and intraspecies ‘‘complementation’’ involves the intercellular exchange of metabolites.Laboratory culture is a mainstay of medi-
cal bacteriology. The ability to grow a
pathogen in pure culture is the basis for
one of Koch’s postulates—the criteria
presented by Robert Koch in 1890 to
establish relationships between individual
pathogens and disease (Fredericks and
Relman, 1996). Since then, much of med-
ical microbiology, including the identifica-
tion of infecting bacteria, testing their
in vitro susceptibilities to antibiotics, and
probing myriad other behaviors, relies on
laboratory growth in pure, single-species
(i.e., ‘‘axenic’’) cultures. These methods
have been refined for well over a century,
resulting in a dizzying array of media
and techniques, and allowing for ever-
improved capacity for bacterial cultiva-
tion, identification, and discrimination.The usefulness of axenic cultures is
undeniable; these techniques have been
invaluable in diagnosing and choosing
treatments for innumerable infections.
These methods have also proven to be
incredibly powerful for investigating the
inner workings of specific pathogens,
including their growth requirements, their
patterns of gene and protein expression,
and even their virulence. Axenic cultures
are particularly effective when applied to
acute infections by a single bacterial spe-
cies. In such cases, it can be relatively
straightforward to pinpoint the pathogen
in question and to identify antibiotics
that should be able to eradicate, or at
least suppress, the infection.
However, there are reasons to question
the accuracy of axenic culture techniqueswhen they are applied to more complex
infections. For example, a single-isolate
culture may not faithfully reflect the
behavior of an organism when multiple
microbes are present in infected tissues,
or during chronic infections, when even
a single species may diversify as it adapts
to the varying selective pressures it might
encounter in those tissues. Pure cultures
of individual isolates from these infec-
tions may underestimate the diversity of
bacteria—both within and among spe-
cies—that contribute to a particular dis-
ease. Without an inclusive accounting of
these infecting microbes, it is difficult
to understand the pathogenesis of poly-
microbial or chronic infections and to
treat them. Specifically, a single bacterial
isolate could behave entirely differently6, October 8, 2014 ª2014 Elsevier Inc. 427
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Figure 1. Impact of Community Interactions on the Growth and Virulence of Slow-Growing
Bacteria
A metabolically deficient small colony variant (SCV, center) has significantly impaired growth and
decreased virulence factor production in vitro and lower bacterial burdens and virulence in an osteomyelitis
infectionmodel (indicatedbygray lesions inbone) compared tobacteriawith normal growth (left). However,
cocultures of two SCVs (SCV-1 and SCV-2, right) with distinct metabolic deficiencies results in enhanced
growth and virulence in vitro and in vivo, probably through the intercellular transfer of metabolites.
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communities comprised either of other
variants of its own species or with other
species. Interactions between different
microbes in such communities could alter
each member’s metabolism, virulence,
and susceptibilities to antibiotics. Many
chronic infections persist despite treat-
ment with antibiotics that effectively kill
each identified pathogen isolated in pure
cultures. Therefore, accurately describing
andmodeling community behaviors could
help to identify improved treatments for
chronic infections, which account for
tremendous morbidity and mortality.
The work described in this issue of Cell
Host & Microbe by Hammer et al. (2014)
provides a provocative example of bac-
terial community interactions at both
intra- and interspecies levels that may
be relevant for many chronic infections,
particularly those that include the com-
mon animal pathogen Staphylococcus
aureus. This gram-positive bacterium
often chronically infects the bones, skin428 Cell Host & Microbe 16, October 8, 2014and soft tissues, and cardiovascular and
respiratory epithelia of diverse mammals
(Lowy, 1998; Peton and Le Loir, 2014),
frequently undergoing metabolic adapta-
tion along the way to become small-col-
ony variants (SCVs). SCVs grow slowly
in axenic cultures, tend to be defective
for producing specific respiratory cofac-
tors, and have reduced virulence (Proctor
et al., 2006). In many cases, such as in the
respiratory tract, S. aureus infects in the
presence of other bacteria with which it
could interact (Boase et al., 2013; Harris
et al., 2007). As shown by at least one
experimental coculture system—with
S. aureus and the gram-negative bacte-
riumPseudomonas aeruginosa—these in-
teractions can select for S. aureus SCVs,
which are in turn resistant to killing by
certain antibiotics (Hoffman et al., 2006).
Work with this and other simple, binary
systems show that microbial community
interactions can select for antibiotic-
resistant variants with decreased fitness
in vitro. Interestingly, SCVs have beenª2014 Elsevier Inc.associated with persistent infections and
worse disease outcomes despite their
impairment in pure culture (Besier et al.,
2007; Wolter et al., 2013), possibly sug-
gesting that their behaviors in vitro may
not accurately reflect those in vivo.
Based on observations of this type,
Hammer et al. (2014) wondered whether
the reduction in fitness observed for
SCVs in axenic cultures might be an arti-
fact of removing these variants from
naturally diverse microbial environments.
The researchers hypothesized that
community interactions between geneti-
cally distinct bacteria would offset the
fitness costs associated with mutations
that confer antibiotic resistance, such as
mutations carried by SCVs. To test this
hypothesis, Hammer et al. (2014) cocul-
tured S. aureus SCVs with different types
of causative mutations and measured the
effects of coculture on growth, intercel-
lular signaling activity, toxin production,
cytotoxicity, antibiotic susceptibility, and
ultimately in vivo pathogenesis in amurine
bone infection model. These experiments
showed that genetically distinct SCVs,
each defective for in vitro and in vivo
growth as single-isolate cultures, can
grow, infect, damage bone tissue, and
otherwise behave with nearly wild-type
characteristics when cocultured with
each other (Figure 1). By using SCVs
with different defined mutations, and
with the clever use of exogenously added
reagents, Hammer et al. (2014) provide
compelling evidence that the mechanism
of this intraspecies ‘‘complementation’’
involves the intercellular exchange of
metabolites, particularly heme. Therefore,
the depiction of the behaviors of individual
isolates provided by traditional, axenic
culture techniques may not reflect their
behaviors in a community context.
The SCV cocultures used in this study
may more accurately reflect the in vivo
behaviors of infectious microbial com-
munities containing these variants than
do single-isolate cultures. However,
while both types of laboratory-derived
S. aureus SCVs used in this study have
been isolated from chronic infections
(such as from airway secretions of people
with cystic fibrosis [CF]) (Proctor et al.,
2006), there had been little evidence in
the literature to date for their coisola-
tion from the same specimens. There-
fore, while these experiments provide
convincing and provocative evidence for
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in principle, their clinical relevance re-
mained to be demonstrated. The re-
searchers began to address this issue
with their next experiments, in which
Hammer et al. (2014) applied similar
methods to study the effects of cocultur-
ing slow-growing isolates of different bac-
terial species (including S. aureus SCVs)
from CF patients’ respiratory secretions.
Intriguingly, these experiments revealed
enhancement of growth by many of these
isolates when cocultured. The bacterial
pairs that grew better together than sepa-
rately included not only different S. aureus
SCVs isolated from the same patient, but
also those same SCVs with isolates of
nonstaphylococcal species, some of
which are considered ‘‘upper respiratory
flora’’ and are often not identified further
by routine clinical diagnostic procedures.
As with the paired S. aureus SCVs,
Hammer et al. (2014) provide evidence,
albeit less complete than with the engi-
neered SCVs, that these growth-promot-
ing interactions are due to the intercellular
exchange of metabolites such as heme,
as well as the respiratory cofactor mena-
quinone. Therefore, both intra- and inter-
species community interactions can
impact the fitness of bacteria, further
underscoring how axenic cultures often
incompletely reflect the behaviors of
complex, chronic infections.These results strongly suggest the
benefits of a communal lifestyle for
slow-growing organisms. However, as
is often the case with provocative find-
ings, they raise several as yet unan-
swered but compelling questions for
future experiments. For example, do all
members involved in these types of in-
teractions benefit? What are the molecu-
lar mechanisms and dynamics of inter-
cellular metabolite transfer; are export
and uptake active or passive? What
happens when community members
who do not grow slowly, and who may
therefore be less likely to benefit from
metabolite exchange, are involved?
How does the host influence these infec-
tious community behaviors? And, per-
haps the most daunting, how do we
identify and model the interactions be-
tween members of a community larger
than two constituents?
As we struggle with these mechanistic
details, an even more practical question
emerges: how should we address the
shortcomings of traditional, axenic cul-
tures, and how can we better diagnose,
study, and treat chronic infections and
the diverse microbial communities that
cause them? At present, such improved
approaches remain to be developed or
successfully tested. However, the results
of studies such as this one, given the
high global burden of chronic, persistentCell Host & Microbe 1infections, provide ample rationale for
such efforts.REFERENCES
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